Pharmaceutical

The promising role of GLP-1RAs in NASH

Research has shown that GLP-1RAs may have the potential to treat chronic metabolic diseases such as non-alcoholic steatohepatitis (NASH).

Jun 29, 2023 - 20:00
The promising role of GLP-1RAs in NASH
Research has shown that GLP-1RAs may have the potential to treat chronic metabolic diseases such as non-alcoholic steatohepatitis (NASH).
Read the original article

Tags:

Previous Article

Cellusion shares pipeline update for eye disease stem cell therapy

Next Article

AI with volumetric thresholds facilitate opportunistic screening for splenomegaly

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Kidney doctors push to protect patients by including dialysis machines in emergency stockpile

Kidney doctors push to protect patients by including di...

Aug 7, 2023

Morning Rounds: Our newsroom’s favorite stories of 2023

Morning Rounds: Our newsroom’s favorite stories of 2023

Dec 23, 2023

TORL BioTherapeutics raises funds to develop new oncology therapies

TORL BioTherapeutics raises funds to develop new oncolo...

Apr 14, 2023